CR845

DRUG4 trials

Sponsors

Cara Therapeutics, Inc.

Conditions

Acute PainPostoperative PainUremic Pruritus

Phase 2

Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

CompletedNCT00877799

Cara Therapeutics, Inc.Acute Pain

Start: 2009-03-31End: 2010-01-31Updated: 2015-05-12

Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery

CompletedNCT01361568

Cara Therapeutics, Inc.Postoperative Pain

Start: 2011-07-31End: 2012-04-30Updated: 2014-05-29

A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery

CompletedNCT01789476

Cara Therapeutics, Inc.Acute Pain

Start: 2013-05-31End: 2013-08-31Updated: 2015-04-30

Phase 3

Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

CompletedNCT03281538

Cara Therapeutics, Inc.Uremic Pruritus

Start: 2017-08-14End: 2020-02-11Updated: 2021-10-14

Related Papers

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program

Kidney Medicine2022-06-2847 citations